🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Suprascapular Nerve Block and Proprioception in Hemiplegic Shoulder Pain: A Randomized Controlled Study

RecruitingNAAges 18 Years - 80 YearsAllFatih Sultan Mehmet Training and Research Hospital
NCT07346755 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this prospective randomized controlled clinical trial is to evaluate the effect of suprascapular nerve block on shoulder joint proprioception in stroke patients with hemiplegic shoulder pain. Fourteen patients aged 18-80 years with hemiplegic shoulder pain will be randomized into two groups. One group will receive suprascapular nerve block followed by a standardized physical therapy program, while the control group will receive the same physical therapy program alone. The primary outcome is shoulder joint proprioception. Secondary outcomes include pain intensity, shoulder range of motion, motor recovery, stroke-specific quality of life, and upper extremity functional outcomes. The results of this study are expected to clarify the role of suprascapular nerve block on proprioception and rehabilitation outcomes in patients with hemiplegic shoulder pain.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age between 18 and 80 years * Presence of shoulder pain on the hemiplegic side with a Numeric Rating Scale (NRS) score \> 3 * At least 1 month since the cerebrovascular event (subacute and chronic stroke patients) * Active shoulder flexion range of motion \> 90 degrees (required for the application of the laser pointer-assisted joint position sense test) * First-ever, unilateral hemiplegia Exclusion Criteria: * Mini-Mental State Examination score \< 24 indicating cognitive impairment * Presence of aphasia * Shoulder spasticity with a Modified Ashworth Scale score \> 2 * Brunnstrom upper extremity motor stage \< 3 * Botulinum toxin type A injection within the last 3 months to muscles affecting shoulder joint movement (trapezius, levator scapulae, pectoralis major, deltoid, serratus anterior, latissimus dorsi, rhomboids, teres major, biceps, coracobrachialis, triceps, supraspinatus, subscapularis, infraspinatus, and teres minor) * Pre-existing shoulder pathology causing pain in the hemiplegic shoulder * Presence of neglect syndrome * Complex regional pain syndrome, central pain, traumatic brachial plexus injury * Change in pain medication during the study period * Hypersensitivity to the medication used for suprascapular nerve block (lidocaine) * Adhesive capsulitis (frozen shoulder) * Other shoulder pathologies such as fractures or joint replacement
💊

What it tests

  • suprascapular nerve block
  • physical therapy
📍

Where

1 site
Fatih Sultan Mehmet Training and Research Hospital Istanbul, İstanbul, Turkey
Istanbul, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy